Wednesday, August 10, 2016

BRIEF-Spark Therapeutics Q2 loss per share $1.04

* Spark therapeutics reports second quarter 2016 financial

results and recent business highlights

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)